Piramal Pharma's topline surged 11.6% year-on-year but fell 24% sequentially to ₹1,951 crore.
CNBC TV18
1 day ago
Paris Olympics 2024: India's Balraj Panwar finishes 4th in men's single sculls heat, moves to repechage - CNBC TV18
4 hours ago
CNBC-TV18 Union Budget Morning Call: All eyes on FM Sitharaman, Wall Street rebounds - CNBC TV18
4 days ago
Welspun Living retains 15-15.5% margin target for FY25 - CNBC TV18
PepsiCo India reports ₹5,954 crore revenue for April-Dec 2023, profit at ₹217 crore - CNBC TV18
3 hours ago
DGFT simplifies Export Promotion Capital Goods Scheme procedures to enhance Ease of Doing Business - CNBC TV18
View all